Recent Headlines
Within Pharmaceuticals
BioPharm Systems to Present at Oracle's 7th Annual Health Sciences Innovation Forum
BioPharm Systems, a leading provider of clinical trial, data, and drug safety solutions, and a Gold level member of Oracle PartnerNetwork (OPN), today announced that Parambir Singh, vice president of clinical trial management solutions, and Dr. Rodney Lemery, vice president of safety and... - April 18, 2012 - BioPharm Systems
TTC Data Shows India Experiencing Sustained Growth in Commercial Clinical Trial Activity
India, with the world's largest pool of clinically ill patients, has more than 500,000 English-speaking doctors, many trained in the United States or the United Kingdom. India has experienced sustained growth in commercial clinical trials, and will soon become the world's third largest... - April 15, 2012 - TTC LLC
Dr. Yong Shi Awarded Patent for Innovative Control of Piezoelectric Nanofibers
Emerging nanofiber technology establishes tiny, self-powering sensors and actuators with compelling commercial applications. - April 14, 2012 - Stevens Institute of Technology
G&G Vitamins Offering New Line of Multivitamins for Women
G&G Vitamins, one of the UK’s leading manufacturers of high quality vitamin and mineral products has announced that they are now releasing a new line of multivitamins for women. The company’s new products are designed to help women around the world to manage their dietary needs with... - April 14, 2012 - G&G Vitamins
TTC a Clinical Trial Organization Standard of Care™ Database Tracks 1.2 Billion Claims Annually
Web-Accessible Standard of Care™ Provides Objective Data on How Sites, Actually Treat Patients Within the Standard of Care - April 13, 2012 - TTC LLC
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
Dr. Simon Podkolzin’s International Green Chemistry Collaboration Wins NSF Grant
Nanoparticle catalysts for industrial chemical reactions use oxygen with only water as a byproduct. - April 12, 2012 - Stevens Institute of Technology
My Perfect Bones Adds Anti Stress Formula to Collection of Natural Organic Products
My Perfect Bones introduces the new Anti Stress Sports Formula to its all natural and organic line of supplements and remedies. The topical cream is used for anti-inflammatory joint and muscle pain relief by stimulating blood flow and accelerating the healing. - April 11, 2012 - My Perfect Bones
Hart Rank Associates Announces the Formation of Med-Pulse and Licensing Agreement with Florida Institute of Technology for Skin Cancer Laser Detection Patented Technology
Hart Rank Associates Announces the formation of Med-Pulse and Licensing Agreement with Florida Institute of Technology for Skin Cancer Laser Detection Patented Technology. The technology enables the development of a laser-based system to be used in doctor’s offices and specialty imaging centers to detect the presence of skin cancer cells in a patient. The in office laser-based system will reduce and/or replace painful, costly & time-consuming biopsies. - April 10, 2012 - Hart Rank Associates
CardioTabs Announces Promotion Partnership with Vitamin Angels
CardioTabs, along with their customers, are working to help Vitamin Angels reach 25 million children in 2012. - April 08, 2012 - CardioTabs
Flexeffect Presents Scientifically Proven Facial Exercises to Get Rid of Undereye Circles and Other Signs of Aging
FlexEffect Facialbuilding is promoting the Third Edition of its facial exercises program, which features techniques backed by new scientific research. - April 07, 2012 - Flex Effect - Facial Exercises
Higher Springtime UV Radiation Identified in Northern Europe
Based on a multi-year EU-funded study (EuroSun), the International Prevention Research Institute (iPRI) in Lyon, has concluded that UV radiation in Europe appears earlier in the year and farther north than originally believed. Data gathered between 1988 and 1992 demonstrates that in spring, parts... - April 06, 2012 - International Prevention Research Institute
ICRC-Weyer to Adjust Services Portfolio in Light of New European Health Claim Regulations
The German based contract research organization, ICRC-Weyer GmbH, has adjusted its services portfolio in order to meet new requirements for the European nutrition market. With the recent fundamental changes for health claims on dietary supplement product labels, manufacturers will have to invest in research and development. But only specialized CROs are able to manage the new challenge. - April 06, 2012 - ICRC-Weyer GmbH
Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors
Four industry executives were named to the Colorado BioScience Association (CBSA) Board of Directors at its 2012 Annual All-Member Meeting. New CBSA director appointments include James Chomas, Ph.D., Founder & CEO, Surefire Medical; Scott Deeter, President & CEO, Ventria Bioscience; Brent Fassett, Partner, Cooley LLP; and Kerry Ingalls, Vice President of Colorado Operations, Amgen. - April 05, 2012 - Colorado BioScience Association
BioPharm Systems to Host Webinar on How to Personalize the Siebel Clinical User Interface
Leading provider of clinical trial, data and drug safety solutions will discuss the various ways one can personalize their Siebel Clinical Trial Management System (CTMS) user interface. - April 05, 2012 - BioPharm Systems
Dr. Birgit Schoeberl to Discuss Using Mathematical Models to Set Design Criteria for Antibody-Based Therapies in Rosa’s "Impact" World-Wide Webinar Series
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. - April 04, 2012 - Rosa & Co LLC
U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer Product Portfolio
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent... - April 04, 2012 - Advanced Cancer Therapeutics
Dr. EH Yang's Research Team Awarded with NSF Grant on Pioneering Microfluidics Innovation
Digital microfluidics creates a lab-on-a-chip, enabling portable at-home medical tests. - April 04, 2012 - Stevens Institute of Technology
Navinode to Launch World’s First All-Carbon Fibre Yacht at the Gold Coast Boat Show 2012 in Hong Kong
Navinode and Delta Powerboats will be launching the world’s first all-carbon fibre yacht in serial production in Asia at the Gold Coast Boat Show 2012 in Hong Kong. - April 01, 2012 - SHL Group (Scandinavian Health Group Ltd)
Rosa to Present Two Lectures at the European Foundation of Medicinal Chemists Conference
Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling - April 01, 2012 - Rosa & Co LLC
MenScience Stacks: A New Way to Get Your Dream Body
MenScience launches new supplement kits to help men reach their nutrition and fitness goals. - March 31, 2012 - MenScience Androceuticals
ImmunoReagents Announces Exclusive Japanese Distribution Channel with Funakoshi Ltd. Co.
ImmunoReagents, a manufacturer of high quality secondary antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Funakoshi as its new distributor for Japan. ImmunoReagents and Funakoshi will work closely together to bring top quality antibodies... - March 31, 2012 - ImmunoReagents Inc.
Nanoindentation Instrumentation for the First Time Under $30K
Nanovea announced the arrival of the N3 line dedicated to providing high-end measurement technology to the broader market. Nanovea has fully automated their measurement techniques while designing to price in the $20K market. - March 31, 2012 - NANOVEA
Genesis Dnepr IVF Celebrates the Births of 1150 IVF Babies
The first Sunday of April is celebrated as the ‘Test Tube Baby’ Day or the White Orchid Day. In the past 10 years, due to Genesis Dnepr in Dnipropetrovsk 1150 IVF babies were born. Ukraine now counts about 16 000 IVF citizens. According to ESHRE overall around 5 million lives had emerged due to the in vitro fertilization method of reproduction (IVF) worldwide. - March 30, 2012 - Genesis Dnepr IVF
Investing in Health Pays Off - Nicaragua
The Roberto Clemente Health Clinic’s Annual Health Care Fair on February 4 was a success, with numbers far surpassing expectations. Around 1,200 residents, who live in the remote communities of southwest Nicaragua, received free health care in Limon 1, Tola, Rivas. Adults patiently waited to... - March 30, 2012 - The Roberto Clemente Health Clinic
EU Novel Foods Approved for Vitamin K2 Ingredient
Chrysalis Health & Beauty have announced the availability of Kappa K2Vital Vitamin K2 MK7 raw material for the UK and export markets following the successful EU Novel foods approval for this essential nutrient. - March 30, 2012 - Chrysalis Health & Beauty Business Solutions Limited
Hometown Urgent Care Opens in Latonia Kentucky
Hometown Urgent Care and WorkCare Center will open in the Latonia Center in front of Kroger. - March 29, 2012 - Hometown Urgent Care
AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group
NovaTeinBio Announces Discount on New Human PEG 20000 ELISA Kit
Boston-based biological reagents provider NovaTeinBio has recently announced that they’re offering a 10% discount on their new Human PEG 20000 ELISA kit. This discount is designed to help medical researchers across the company to consolidate the cost of their testing in order to refocus their... - March 28, 2012 - Novatein Biosciences
The Jon Block Group Initiates First Tennis Sponsorship with David Konstantinov
Expanding upon the firm’s tremendously successful sponsorship program in motorcycle road racing, The Jon Block Group is pleased to announce its first tennis sponsorship with an endorsement of 17 year old San Francisco native, David Konstantinov. As succinctly put by Kurt Burgess, the... - March 27, 2012 - Jon Block Group
Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit
Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012 - Rosa & Co LLC
BioPharm Systems Launches Accel-Account Manager for Creating and Managing Oracle Clinical, RDC and TMS User Accounts
Accel-Account Manager allows life sciences companies to easily and cost-effectively manage user accounts without technical knowledge. - March 25, 2012 - BioPharm Systems
Dr. Henry Du Elected SPIE Fellow
Professor Du's interdisciplinary fiber-optic sensing research advances applications in environmental monitoring, medical diagnosis and energy production - March 25, 2012 - Stevens Institute of Technology
ImpactRx Acquires AlphaDetail
Addition of AlphaDetail’s global custom market research expertise enhances and expands company’s solutions offerings. - March 25, 2012 - ImpactRx, Inc
New Clinically Proven Sleep Remedy Launched with Free Promotional Give Away
Opti Sleep the new clinically proven natural sleep solution has been launched with a Free 2 weeks trail such is the confidence of the developers. - March 24, 2012 - Opti Sleep
World Leaders to Address Challenges and Technology Breakthroughs in Sample Preparation for Pathogen Detection at 5th Sample Prep Conference in San Diego, May 3-4
Leading organizations from around the world will convene in San Diego for the Knowledge Foundation’s 5th Sample Prep conference which will take place at the Hilton Resort & Spa from May 3-4, 2012. - March 24, 2012 - Knowledge Foundation
Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology
Modeling analysis enables development of biomarkers for beta cell mass. - March 24, 2012 - Rosa & Co LLC
pharmaCline Partners with The Balancing Act on Lifetime Television
pharmaCline, an innovative pharmaceutical company is partnering with The Balancing Act on Lifetime Television in a four part mini-series to discuss First Aid Wound Care for every member of your family. - March 24, 2012 - pharmaCline
Carotech to Showcase Natural Palm Mixed Carotene (Caromin) & Palm Tocotrienol Complex (Tocomin) at FIC 2012, Shanghai
Carotech will share latest scientific developments and application strategies of its Tocomin and Caromin series of ingredients - March 24, 2012 - Carotech Inc.
Medimix International and Sanofi Pasteur to Present Results of Social Media Monitoring Study PMRG ANC - Orlando, March 27th, 2012
Medimix International and Sanofi Pasteur will present at the PMRG ANC results of an innovative social media study which used a powerful new tracking platform to monitor social media conversations around the globe. Scouring sites representative of English, Spanish, French, Portuguese, German and Chinese (or 80% of the languages used by online populations), the flagged mentions were analyzed by both machine and human to correctly categorize content, overall sentiment, and identify influencers. - March 23, 2012 - Medimix International
Keys to Successful Health Industry Alliances with China
Cypin Production Conference Offers Insights in R&D…and Beyond - March 23, 2012 - CYPIN PRODUCTION LLC
Office of Naval Research Continues Funding for Innovative Research in Unmanned Naval Vessels
ACCeSS collaborators push the boundaries of naval technology and education. - March 23, 2012 - Stevens Institute of Technology
The Spine Health Foundation to Present at the 2012 Global Health & Innovation Conference at Yale University
The Spine Health Foundation was selected to present a social enterprise pitch at the 2012 Global Health and Innovation Conference at Yale University in April. Dr. Morgan Lorio, Orthopedic Surgeon and Official Spokesperson for the foundation will speak on "Eliminating Disparity in Healthcare for the Disadvantaged." - March 22, 2012 - The Spine Health Foundation, Inc.
Control Blood Sugar Using Social Medicine
Diabetes is on the rise, yet a healthy lifestyle change can help control blood sugar levels. Your blood sugar levels can be improved by making small changes in the way you eat, adding in a little more exercise, and losing even a modest amount of weight. - March 22, 2012 - Social-medicine.org
AnaSpec Develops AMC Resins for SPPS
Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group
Viachem to Represent AkzoNobel’s Akucell® Food-Grade Cellulose Gum Additives
Viachem Sales and Marketing to Target Food, Bakery, Beverage and Processed Food Manufacturers that Use Specialty Ingredients and Food Additives in Their Products - March 21, 2012 - Viachem, Ltd.
ALS Therapy Development Institute Announces Eighth Annual "The Cure Is Coming" 5k and Awareness Walk
Participants walk, ride or race to raise money and awareness to end ALS (Lou Gehrig's disease) - March 21, 2012 - ALS Therapy Development Institute
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO
Foamix’s Minocycline Foam – 100% Effective in Impetigo Phase II Clinical Trial with No Side Effects. 80% Improved Significantly After 3 Days of Treatment.
Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012 - Foamix Ltd
Colorado BioScience Association Commends PhRMA and We Work For Health for Showcasing the Critical Importance of Clinical Trials to Chronic Disease Sufferers in the State
Members of Colorado BioScience Association (CBSA) today joined with colleagues from both the public and private sectors, including Colorado Governor John Hickenlooper, at a State Capitol News Conference to applaud the release of PhRMA's new report: “Research in Your Backyard.” Colorado's biopharmaceutical industry assists sufferers of chronic disease and includes approximately 300 companies employing over 5,410 with average salaries of $93,000. - March 19, 2012 - Colorado BioScience Association